Literature DB >> 856604

Serum glycoside concentrations after single or repeated intravenous doses of beta-methyl-digoxin and digoxin.

J Marinow, A Olcay, W Schaumann, W Weiss.   

Abstract

The aim of the present investigation was to estimate the ratio of the intravenous doses of beta-methyl-digoxin and digoxin required to produce identical serum glycoside concentrations in man. 20 patients on intravenous maintenance therapy were changed from beta-methyl-digoxin to the identical dose of digoxin or vice versa. Each drug was given for 7 days. Serum concentrations 13% higher were found during administraton of beta-methyl-digoxin. Assuming a half life of 60 h after withdrawal, the dose of digoxin producing the same minimum serum concentration was estimated to be 1.16 times higher than that of beta-methyl-digoxin. 18 healthy volunteers received 0.4 mg beta-methyl- digoxin, and 23 the same dose of digoxin, as an intravenous infusion over 2 h. The serum concentrations and urinary glycoside excretion were measured over a period of 32 hrs. During the first hour after the infusion the serum concentration of digoxin declined more rapidly than that of beeta-methyl-digoxin. Thereafter, the ratio of the serum concentrtions did not change appreciably up to the end of the investigation. The area under the serum concentration/time curve was about 13% greater for beta-methyl-digoxin than for digoxin; this difference was not significant. The average renal clearance was 96 +- 9 ml for beta-methyl-digoxin, 151 +- 13 ml for digoxin. Since the total body clearance of digoxin is only about 1.16 times higher than that of beta-methyl-digoxin, the lower renal clearance of beta-methyl-digoxin must partly be compensated by higher extrarenal clearance. From the ratios of the areas under the serum concentration/time curves after single doses of beta-methyl-digoxin and digoxin, and the minimum serum concentrations during maintenance therapy, it was concluded that the dose of digoxin to produce the same average serum concentrations would be about 1.15 times higher than that of beta-methyl-dogoxin. In comparison wtih the large variations in individual dosage of digoxin and beta-methyl-digoxin, this difference is too small to be of practical importance.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 856604     DOI: 10.1007/BF00606413

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  23 in total

1.  [Cardiac effects and glycoside concentrations in serum and urine after oral administration of beta-methy-digoxin to healthy individuals (author's transl)].

Authors:  R Haasis; D Larbig; K O Klenk
Journal:  Klin Wochenschr       Date:  1975-06-01

2.  Plasma half life of beta-methyl digoxin following repetitive application in man.

Authors:  G G Belz; U R Kleeberg
Journal:  Klin Wochenschr       Date:  1975-05-15

3.  Demethylation and cleavage of glycosidic bonds of 4'''-methyldigoxin in man.

Authors:  N Rietbrock; C Rennekamp; H Rennekamp; K von Bergmann; U Abshagen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

4.  Beta-methyl-digoxin. VII. Tissue distribution, positive inotropic and central action in cats in comparison with other digitalis glycosides.

Authors:  W Schaumann; K Koch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

5.  [Metabolism and pharmacokinetics of lanatosides in man].

Authors:  N Rietbrock; U Abshagen
Journal:  Dtsch Med Wochenschr       Date:  1973-01-19       Impact factor: 0.628

6.  [Determination of serum-digoxin concentrations by radioimmunoassay].

Authors:  D Larbig; K Kochsiek
Journal:  Klin Wochenschr       Date:  1971-09-15

7.  [Behavior of cardiac glycosides in human organism. A review based on the example of digoxin and lanatoside C].

Authors:  R Blankart
Journal:  Ther Umsch       Date:  1971-04

8.  Relationship of the excretion of tritiated digoxin to renal function.

Authors:  P M Bloom; W B Nelp; S H Tuell
Journal:  Am J Med Sci       Date:  1966-02       Impact factor: 2.378

9.  Administration of tritiated digoxin with and without a loading dose. A metabolic study.

Authors:  F I Marcus; L Burkhalter; C Cuccia; J Pavlovich; G G Kapadia
Journal:  Circulation       Date:  1966-11       Impact factor: 29.690

10.  [Gycoside serum concentrations under maintenance therapy with Lanicor, Card-Lamuran, MF708d, and Lanitop (author's transl)].

Authors:  W Weiss; A Olcay; W Teufel; M Glocke
Journal:  Med Klin       Date:  1975-08-29
View more
  2 in total

1.  Evaluation of medigoxin in outpatients.

Authors:  W R Smith; E M Rodgers; P W Nicholson; R P Humm; D A Gettins; S M Dobbs; A A Deshmukh
Journal:  Eur J Clin Pharmacol       Date:  1981-03       Impact factor: 2.953

2.  Pharmacokinetics of metildigoxin and digoxin in geriatric patients with normal and elevated serum creatinine levels.

Authors:  B Kaufmann; A Olcay; W Schaumann; W Teufel; W Weib
Journal:  Clin Pharmacokinet       Date:  1981 Nov-Dec       Impact factor: 6.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.